Monday , June 27 2022
  • News
    • Industry News
      • Biosimilars
      • Business News
      • Cannabis Based Medicine
      • FDA News
      • Medical News
      • Precision Medicine
      • Press Releases
      • Specialty Pharmacy
      • Technology & Devices
    • Clinical News
      • Autoimmune Disorders
      • Crohn’s Disease
      • Endocrinology
      • Hematopoietics
      • Hemophilia
      • Hepatitis C
      • Hereditary Angioedema
      • HIV/AIDS
      • Hormonal Therapies
    • Clinical News
      • Immune Deficiencies
      • Infectious Diseases
      • Infertility
      • Lysosomal Storage Disorders
      • Macular Degeneration
      • Multiple Sclerosis
      • Nephrology
      • Oncology
      • Osteoarthritis
    • Clinical News
      • Osteoporosis
      • Psoriasis
      • Pulmonary Diseases
      • Rare Diseases
      • Renal Diseases
      • Rheumatoid Arthritis
      • Transplantation
      • Ulcerative Colitis
      • Von Willebrand Disease
  • Special Editions
  • Our Blog
  • Education
  • Media Inquiry
  • Archive
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
  • Contact
  • Subscribe
  • Specialty Pharma Jobs
    • Post a Job
    • Search Jobs

Specialty Pharma JournalSpecialty Pharma Journal Specialty, Precision & Technology

Accredited Continuing Education for Healthcare Professoinals
Specialty Pharma Journal
  • News
    • Industry News
      • Biosimilars
      • Business News
      • Cannabis Based Medicine
      • FDA News
      • Medical News
      • Precision Medicine
      • Press Releases
      • Specialty Pharmacy
      • Technology & Devices
    • Clinical News
      • Autoimmune Disorders
      • Crohn’s Disease
      • Endocrinology
      • Hematopoietics
      • Hemophilia
      • Hepatitis C
      • Hereditary Angioedema
      • HIV/AIDS
      • Hormonal Therapies
    • Clinical News
      • Immune Deficiencies
      • Infectious Diseases
      • Infertility
      • Lysosomal Storage Disorders
      • Macular Degeneration
      • Multiple Sclerosis
      • Nephrology
      • Oncology
      • Osteoarthritis
    • Clinical News
      • Osteoporosis
      • Psoriasis
      • Pulmonary Diseases
      • Rare Diseases
      • Renal Diseases
      • Rheumatoid Arthritis
      • Transplantation
      • Ulcerative Colitis
      • Von Willebrand Disease
  • Special Editions
  • Our Blog
  • Education
  • Media Inquiry
  • Archive
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
  • Contact
  • Subscribe
  • Specialty Pharma Jobs
    • Post a Job
    • Search Jobs
Breaking News
  • FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
  • Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM
  • Natera Announces SMART Study Data for Aneuploidy and 22q Unblinded
  • Aimmune Agrees to be Acquired by Nestlé Health Science for $2 Billion
  • Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program
  • Final Analysis of the Observational GioTag Study: Sequential Afatinib and Osimertinib in Patients with EGFR Mutation-Positive NSCLC
  • Santhera Exercises Option to Obtain Worldwide Rights to Vamorolone in Duchenne Muscular Dystrophy and All Other Indications
  • FDA Approves Onureg, a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia
  • FDA Accepts Vertex’s sNDA for Trikafta, Symdeko and Kalydeco for Additional CFTR Mutations
  • Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Home/Specialty Pharma Jobs/Post a Job

Post a Job

[wpjb_jobs_add]
Share
  • Facebook
  • Twitter
  • LinkedIn

Latest News

  • FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

    September 8, 2020
  • Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM

    September 2, 2020
  • Natera Announces SMART Study Data for Aneuploidy and 22q Unblinded

    September 2, 2020

From Our Blog

  • The 2017 Hepatitis C Treatment Landscape

    February 22, 2017
  • Understanding the Hepatitis C Testing Process

    February 15, 2017
  • Potential New Medication for Lymphoma

    February 8, 2017
© Copyright 2022, Specialty Pharma Journal, All Rights Reserved